• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ULTRAFLEX TRACHEOBRONCHIAL; PROSTHESIS, TRACHEAL, EXPANDABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ULTRAFLEX TRACHEOBRONCHIAL; PROSTHESIS, TRACHEAL, EXPANDABLE Back to Search Results
Model Number M00564760
Device Problems Difficult to Remove (1528); Activation Failure (3270)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/25/2022
Event Type  malfunction  
Event Description
It was reported to boston scientific corporation on (b)(6) 2022 that an ultraflex tracheobronchial covered distal release stent was to be implanted in the bronchial tube for the treatment of esophageal cancer during a bronchial stent placement procedure performed on (b)(6) 2022.The patient's anatomy was not tortuous and was not dilated prior to stent placement.During the procedure, the ultraflex tracheobronchial stent was deployed; however, upon checking under fluoroscopy immediately after deployment, it was noted that the ultraflex tracheobronchial stent did not expand.The delivery system was attempted to be removed; however, it got caught on the ultraflex tracheobronchial stent.The ultraflex tracheobronchial stent was removed together with the delivery system.Another ultraflex tracheobronchial stent was used to complete the procedure.There were no patient complications as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was reported to boston scientific corporation on (b)(6) 2022, that an ultraflex tracheobronchial covered distal release stent was to be implanted in the bronchial tube for the treatment of esophageal cancer during a bronchial stent placement procedure performed on (b)(6) 2022.The patient's anatomy was not tortuous and was not dilated prior to stent placement.During the procedure, the ultraflex tracheobronchial stent was deployed; however, upon checking under fluoroscopy immediately after deployment, it was noted that the ultraflex tracheobronchial stent did not expand.The delivery system was attempted to be removed; however, it got caught on the ultraflex tracheobronchial stent.The ultraflex tracheobronchial stent was removed together with the delivery system.Another ultraflex tracheobronchial stent was used to complete the procedure.There were no patient complications as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Manufacturer Narrative
Block h6: imdrf device code a150207 captures the reportable event of delivery system difficult to remove.Imdrf device code a150101 captures the reportable event of stent failure to expand.Block h10: an ultraflex tracheobronchial distal release covered stent and delivery system were received for analysis.Visual examination of the returned device found the stent fully expanded.The shaft was bent.A media inspection was performed of a photo provided by the complainant, and it was observed that one section of the stent was not fully expanded.No other issues to the stent and delivery system were noted.The reported event of stent failure to expand was confirmed.The reported event of delivery system difficult to remove could not be confirmed; the failure occurred during the procedure, and it is not possible to replicate in the laboratory of analysis.Based on all available information, the investigation concluded that the reported events and the observed failures were likely due to factors encountered during the procedure.It may be that lesion characteristics, how the device was handled, the technique used by the user and/ or normal procedural difficulties encountered, limited the performance of the device and may have contributed to stent unable to expand and shaft bent.Therefore, a review and analysis of all available information indicated the most probable cause is adverse event related to the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAFLEX TRACHEOBRONCHIAL
Type of Device
PROSTHESIS, TRACHEAL, EXPANDABLE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key15414654
MDR Text Key306239768
Report Number3005099803-2022-05201
Device Sequence Number1
Product Code JCT
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K012883
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/08/2023
Device Model NumberM00564760
Device Catalogue Number6476
Device Lot Number0027103521
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/25/2022
Initial Date FDA Received09/13/2022
Supplement Dates Manufacturer Received09/26/2022
Supplement Dates FDA Received10/14/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/08/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-